Tagged with Indonesia

Opinion Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for the political landscape in healthcare for 2019.  The challenges for firms are painfully apparent—there is bipartisan support in the US to lower drug prices, a pervasive sense that traditional advocacy methods are failing in today’s political climate,…

Indonesia The Top 15 pharma companies in Indonesia for 2016. Local giant Kalbe Farma leads the way.

Indonesia Indonesia in figures. Indonesia’s population is projected to grow to 305.6 million by 2035. Indonesia’s universal healthcare coverage program (JKN) has grown exponentially in recent years to cover around 172 million people in 2016. Indonesia spends less on healthcare than many of its regional peers, with only Laos and Myanmar…

Indonesia Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages in innovation beyond products. Since 2012, Merck has been implementing “Fit for 2018” – a transformation program aiming to drive the growth of the company globally. How has this…

Indonesia Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the sales growth rate achieved by Darya-Varia Laboratoria was 11 percent, above market average. What business approach is the secret to…

Indonesia Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and education. The former global President & CEO of GE Healthcare, John Flannery, has recently been appointed as global President &…

Indonesia Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out to ensure that all Indonesians have access to medicines and how the Indonesian pharmaceutical industry has developed its self-reliance and innovativeness. How does the Ministry of Health organize its priorities and how far…

Indonesia The Halal Product Assurance Law, enacted in 2014 and due to be implemented across Indonesia in 2019, will mandate that all food and drink that that enters, is distributed, and is traded in Indonesia must be halal certified. However, the law will also extend to cover all medicines, chemicals and…

Indonesia Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since assuming his current position and the organization’s business expansion strategy, based on enhancing patient access to innovative medicines in both the public and private sectors. Mr. Paleja, you were appointed as country president and general…

Indonesia Aylie Widjaja, managing director at Exeltis Indonesia, shares her excitement about developing the company’s footprint in Indonesia, making it a manufacturing hub for Asia, and highlights the challenges in navigating the public market. How do you see the Indonesian healthcare landscape evolving? “We have to give better options to patients…

Indonesia Patrick Kalona, Director at Phytochemindo Reksa draws a detailed picture of the traditional and herbal medicine industry in Indonesia in addition to presenting the internationalization and growth strategy for the company. In parallel to your position at Phytochemindo Reksa you are also Chairman of the Indonesian Health Supplement Association (APKSI)…

Indonesia Benoit Martineau, President Director at Sanofi Indonesia, explains the transformation of the Indonesian affiliate and reaffirms the strong commitment of Sanofi in helping the Indonesian government to successfully implement their patient access roadmap. Mr. Martineau, could you please introduce yourself to our international audience as well as your main areas…